David Abrams - Abrams Capital Management,
Holding/activity history for Nuvation Bio Inc. (NUVB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,270,504 | 0.12 | Reduce 66.67% | 0.40 | $4.29 | $5,450,462 | SEC |
| 2025 Q4 | 3,811,513 | 0.60 | $8.96 | $34,151,156 | SEC | ||
| 2025 Q3 | 3,811,513 | 0.23 | $3.70 | $14,102,598 | SEC | ||
| 2025 Q2 | 3,811,513 | 0.12 | $1.95 | $7,432,450 | SEC | ||
| 2025 Q1 | 3,811,513 | 0.12 | $1.76 | $6,708,263 | SEC | ||
| 2024 Q4 | 3,811,513 | 0.16 | $2.66 | $10,138,625 | SEC | ||
| 2024 Q3 | 3,811,513 | 0.14 | $2.29 | $8,728,365 | SEC | ||
| 2024 Q2 | 3,811,513 | 0.22 | $2.92 | $11,129,618 | SEC | ||
| 2024 Q1 | 3,811,513 | 0.43 | $3.64 | $13,873,907 | SEC | ||
| 2023 Q4 | 3,811,513 | 0.18 | $1.51 | $5,755,385 | SEC | ||
| 2023 Q3 | 3,811,513 | 0.17 | $1.34 | $5,107,427 | SEC | ||
| 2023 Q2 | 3,811,513 | 0.20 | $1.80 | $6,860,723 | SEC | ||
| 2023 Q1 | 3,811,513 | 0.20 | $1.66 | $6,327,112 | SEC | ||
| 2022 Q4 | 3,811,513 | 0.26 | $1.92 | $7,318,105 | SEC | ||
| 2022 Q3 | 3,811,513 | 0.25 | $2.24 | $8,538,000 | SEC | ||
| 2022 Q2 | 3,811,513 | 0.33 | $3.24 | $12,349,000 | SEC | ||
| 2022 Q1 | 3,811,513 | 0.47 | $5.26 | $20,049,000 | SEC | ||
| 2021 Q4 | 3,811,513 | 0.71 | $8.50 | $32,398,000 | SEC | ||
| 2021 Q3 | 3,811,513 | 0.83 | $9.94 | $37,886,000 | SEC | ||
| 2021 Q2 | 3,811,513 | 0.79 | $9.31 | $35,485,000 | SEC | ||
| 2021 Q1 | 3,811,513 | 0.77 | Buy | 0.77 | $8.92 | $33,989,000 | SEC |